Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation
- PMID: 31359472
- DOI: 10.1111/apt.15300
Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation
Comment on
-
Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.Aliment Pharmacol Ther. 2019 May;49(10):1260-1273. doi: 10.1111/apt.15253. Epub 2019 Apr 15. Aliment Pharmacol Ther. 2019. PMID: 30989721
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical